Organon & Co. (OGN)
13.34
+0.02
(+0.15%)
USD |
NYSE |
Apr 29, 16:00
13.32
-0.02
(-0.19%)
Pre-Market: 05:33
Organon EPS Diluted (Quarterly) : -0.7879 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Abbott Laboratories | 0.6165 |
| Gilead Sciences, Inc. | 1.742 |
| Replimune Group, Inc. | -0.7694 |
| Hims & Hers Health, Inc. | 0.0893 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -205.00M |
| Revenue (Quarterly) | 1.507B |
| Total Expenses (Quarterly) | 1.712B |
| Enterprise Value | 11.70B |
| Gross Profit Margin (Quarterly) | 50.36% |
| Profit Margin (Quarterly) | -13.60% |
| Earnings Yield | 5.37% |
| Operating Earnings Yield | 35.80% |
| Normalized Earnings Yield | 12.46 |